Albuterol Inhalation Soln Rx
Generic Name and Formulations:
Albuterol (as sulfate) 0.63mg/3mL (0.021%), 1.25mg/3mL (0.042%); preservative-free.
Various generic manufacturers
Indications for Albuterol Inhalation Soln:
<2yrs: not recommended. ≥2yrs: 1 vial by nebulizer 3–4 times daily over 5–15 mins.
Avoid excessive use. Sensitivity to sympathomimetics. Consider higher dose albuterol product in acute attack. Discontinue if paradoxical bronchospasm or cardiovascular effects occur. Cardiovascular disease (eg, coronary insufficiency, arrhythmias, hypertension). Diabetes. Hyperthyroidism. Seizure disorders. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended.
Avoid MAOIs, tricyclics within 14 days (increased cardiovascular effects). Other short-acting sympathomimetics: not recommended. Antagonized by β-blockers. Monitor digoxin. Caution with other drugs that lower serum potassium (eg, diuretics).
Tremor, nervousness, headache, dizziness, hyperactivity, insomnia, weakness, tachycardia, epistaxis, hypokalemia, local irritation (inh), paradoxical bronchospasm, rash.
Formerly known under the brand name AccuNeb.
Endocrinology Advisor Articles
- Update on Vitamin D and Calcium Supplements for Reducing Fracture Risk
- AAP Shares List of 5 Unnecessary Pediatric Tests and Procedures
- Severe Hypoglycemia Associated With Increased Mortality Risk in T2D
- Efficacy of CGM in Preterm Infants of Mothers With Diabetes
- SSRIs and SNRIs Linked to Type 2 Diabetes in Children, Adolescents
- High Grip Strength Associated With Lower Risk for Diabetes-Related AEs
- Statin Use for CVD Prevention Increases Diabetes Risk in Overweight Patients
- Optimal Timing of Gastric Bypass and Cholecystectomy When Both Procedures Clinically Indicated
- Does Asthma Contribute to Infertility?
- Short-Term Probiotics Increase Weight Loss in Overweight, Obesity